Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Maiwenn J Al"'
Autor:
Fernando Albuquerque de Almeida, Maiwenn J. Al, Ron Koymans, Jarno Riistama, Steffen Pauws, Johan L. Severens
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Empirical identification of the direct impact of hospitalisation in the change in utility could provide an interpretation for some of the unexplained variance in quality of life responses in clinical practice and clinical trials a
Externí odkaz:
https://doaj.org/article/5d174598453b43a395e72f7e1a3eb553
Autor:
Celine Johanna van de Laar, Carly A Janssen, Matthijs Janssen, Martijn A H Oude Voshaar, Maiwenn J Al, Mart A F J van de Laar
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0261940 (2022)
ObjectivesTo assess the cost-effectiveness of various combinations of urate lowering therapy (ULT) and anti-inflammatory treatment in the management of newly diagnosed gout patients, from the Dutch societal perspective.MethodsA probabilistic patient-
Externí odkaz:
https://doaj.org/article/361aa4cc51414e9d9e7c651fb9b4ce5b
Publikováno v:
BMC Family Practice, Vol 19, Iss 1, Pp 1-11 (2018)
Abstract Background In an ageing population, it is inevitable to improve the management of care for community-dwelling elderly with incontinence. A previous study showed that implementation of the Optimum Continence Service Specification (OCSS) for u
Externí odkaz:
https://doaj.org/article/163cc2fff7e94400a5c7889b9cb49f59
Autor:
Marscha S. Holleman, Simone A. Huygens, Maiwenn J. Al, Malou C. P. Kuppen, Hans M. Westgeest, Alfonsus C. M. van den Bergh, Andries M. Bergman, Alfonsus J. M. van den Eertwegh, Mathijs P. Hendriks, Menuhin I. Lampe, Niven Mehra, Reindert J. A. van Moorselaar, Inge M. van Oort, Diederik M. Somford, Ronald de Wit, Agnes J. van de Wouw, Winald R. Gerritsen, Carin A. Uyl-de Groot
Publikováno v:
Drugs-Real World Outcomes, 9(2), 275-285. Springer International Publishing AG
Drugs – Real World Outcomes, 9. SPRINGERNATURE
Drugs-Real World Outcomes, 9, 275-285
Holleman, M S, Huygens, S A, Al, M J, Kuppen, M C P, Westgeest, H M, van den Bergh, A C M, Bergman, A M, van den Eertwegh, A J M, Hendriks, M P, Lampe, M I, Mehra, N, van Moorselaar, R J A, van Oort, I M, Somford, D M, de Wit, R, van de Wouw, A J, Gerritsen, W R & Groot, C A U 2022, ' Being Transparent About Brilliant Failures : An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 275-285 . https://doi.org/10.1007/s40801-022-00294-7
Drugs-Real World Outcomes, 9, 2, pp. 275-285
Drugs – Real World Outcomes, 9. SPRINGERNATURE
Drugs-Real World Outcomes, 9, 275-285
Holleman, M S, Huygens, S A, Al, M J, Kuppen, M C P, Westgeest, H M, van den Bergh, A C M, Bergman, A M, van den Eertwegh, A J M, Hendriks, M P, Lampe, M I, Mehra, N, van Moorselaar, R J A, van Oort, I M, Somford, D M, de Wit, R, van de Wouw, A J, Gerritsen, W R & Groot, C A U 2022, ' Being Transparent About Brilliant Failures : An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer ', Drugs-Real World Outcomes, vol. 9, no. 2, pp. 275-285 . https://doi.org/10.1007/s40801-022-00294-7
Drugs-Real World Outcomes, 9, 2, pp. 275-285
Contains fulltext : 251781.pdf (Publisher’s version ) (Open Access) BACKGROUND: Real-world disease models spanning multiple treatment lines can provide insight into the (cost) effectiveness of treatment sequences in clinical practice. OBJECTIVE: Ou
Autor:
Evo Alemao, Maiwenn J Al, Annelies A Boonen, Matthew D Stevenson, Suzanne M M Verstappen, Kaleb Michaud, Michael E Weinblatt, Maureen P M H Rutten-van Mölken
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205013 (2018)
The objective of this study was to evaluate current approaches to economic modeling in rheumatoid arthritis (RA) and propose a new conceptual model for evaluation of the cost-effectiveness of RA interventions. We followed recommendations from the Int
Externí odkaz:
https://doaj.org/article/4187b2f613c94bdf83eddab2af8e7526
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171292 (2017)
BACKGROUND:Decision-analytic cost-effectiveness (CE) models combine many parameters, often obtained after meta-analysis. AIM:We compared different methods of mixed-treatment comparison (MTC) to combine transition and event probabilities derived from
Externí odkaz:
https://doaj.org/article/2d9accdff8f34e1aa586973470a362d3
Autor:
Maiwenn J. Al1 m.al@erasmusmc.nl, Maniadakis, Nikos2, Grijseels, Els W. M.3, Janssen, Matthijs4
Publikováno v:
Value in Health. Jul/Aug2008, Vol. 11 Issue 4, p589-599. 11p. 1 Diagram, 5 Charts, 1 Graph.
Autor:
Siok Swan, Tan, Leona, Hakkaart-van Roijen, Maiwenn J, Al, Clazien A, Bouwmans, Marga E, Hoogendoorn, Peter E, Spronk, Jan, Bakker
Publikováno v:
Journal of intensive care medicine. 23(4)
The primary objective of this study was to estimate the actual daily costs of intensive care unit stay using a microcosting methodology. As a secondary objective, the degree of association between daily intensive care unit costs and some patient char
Autor:
Leida M, Lamers, Roger, Stupp, Martin J, van den Bent, Maiwenn J, Al, Thierry, Gorlia, Jean-Blaise, Wasserfallen, Nicole, Mittmann, Soo, Jin Seung, Ralph, Crott, Carin A, Uyl-de Groot, R O, Mirimanoff
Publikováno v:
Cancer, 112, 6, pp. 1337-44
Cancer, 112, 1337-44
Cancer, 112(6), 1337-1344. John Wiley & Sons Inc.
Cancer, 112, 1337-44
Cancer, 112(6), 1337-1344. John Wiley & Sons Inc.
BACKGROUND. The study aimed to compare the cost-effectiveness of concomitant and adjuvant temozolomide (TMZ) for the treatment of newly diagnosed glioblastoma multiforme versus initial radiotherapy alone from a public health care perspective. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6365794ddac0bd5467e666b0691f3a
https://hdl.handle.net/2066/70542
https://hdl.handle.net/2066/70542
Publikováno v:
Swiss medical weekly. 134(3-4)
An outpatient setting typically includes experienced and novice resident physicians who are supervised by senior staff physicians. The performance of this kind of outpatient setting, for a given mix of experienced and novice resident physicians, is d